BioSpace News Archive

Utilizing AI technology to streamline information analysis and contribute to progress in an emergent, yet vital frontier of medical science

Orgenesis Inc. announced it has been ranked the 5th fastest growing technology company in Maryland and 208th in North America on Deloitte’s 2019 Technology Fast 500, a ranking of the 500 fastest growing technology, media, telecommunications, life sciences and energy tech companies in North America.

Eisai Co., Ltd. has announced that LENVIMA, the orally available kinase inhibitor discovered by Eisai, has been accepted by the National Medical Products Administration of China for an application for the additional indication of differentiated thyroid cancer.

€8 million acquisition brings a wide range of revenue-generating products in orthopaedic, spine, dental and sports surgery

BioMed X announced the successful completion of their first joint research project with Boehringer Ingelheim in the fields of chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis.

According to PhRMA, there are 264 vaccines in development to prevent and treat diseases. These include infectious diseases (137), cancer (101), allergies (10), autoimmune disease (8) and Alzheimer’s disease (4).

Experienced financial leader joins Xenikos as they enter the final stage of clinical development of T-Guard®

CRO to lead discussion on “New Pathways to Approval” and engage with local talent to fill data science positions

As a global leading supplier of of raw materials, antibodies, and reagents for bio-technology industry, Creative Diagnostics launches a large range of foodborne pathogen antibodies and antigens, which have been validated to work in various types of immunoassays and can be supplied as high quality tools for the detection of foodborne pathogens.

Columbia, SC – Obsidio, Inc., a pre-clinical stage medical materials developer pioneering a universal embolic hydrogel designed to be delivered minimally invasively through a clinical catheter for blood vessel occlusion, announced the formation of its clinical advisory board.